|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/74 | |
| C07K 7/00 | |||
| C12Q 1/56 | |||
| A61K 38/43 |
| (11) | Number of the document | 3062813 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14805360.6 |
| Date of filing the European patent application | 2014-10-21 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2014/000056 |
| Date | 2014-10-21 |
| (87) | Number | WO 2015/063753 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 22913413 | 2013-10-29 | IL | |
| 201361896674 P | 2013-10-29 | US |
| (72) |
ORR, Nadav, IL
PILPEL, Yair, IL
DORON, Sivan, IL
|
| (73) |
Omrix Biopharmaceuticals Ltd.,
Bldg.14 Weizmann Science Park P.O. Box 619, Rehovot 7610601,
IL
|
| (54) | COMPOUNDS AND METHODS FOR STABILIZING THROMBIN ACTIVITY |
| COMPOUNDS AND METHODS FOR STABILIZING THROMBIN ACTIVITY |